Log in  First Connection?

Kidney TransplantationArchives

A population pharmacokinetic model for early follow-up dosing of tacrolimus in Tunisian kidney transplant recipients

 Published on 14/01/2026 |  Original article (Full-text)  | Amani Abderahmene et al. | Personalized Medicine 2026; aop:10.1080/17410541.2025.2606641

Tacrolimus is the cornerstone of immunosuppressive therapy in kidney transplantation. However, it exhibits significant pharmacokinetic (PK) variability among patients. Therefore, Population Pharmacokinetic (PopPK) modeling is crucial for personalized tacrolimus treatment. While PopPK models have been...

Complete kidney allograft extrusion through a dehiscent wound following graft thrombosis and immunosuppression withdrawal: a case report

 Published on 07/01/2026 |  Original article (Full-text)  | Madadov Islam K. et al. | BMC Nephrology 2025; 26(1): 708

Kidney transplantation is the definitive treatment for patients with end-stage renal disease. Compared to dialysis, it offers superior survival and quality of life [1, 2–3]. Despite its advantages, the procedure is associated with surgical risks. Among them, wound complications influence graft...

Prevalence, clinical features, and seasonal patterns of SARS-CoV-2, influenza, and HRSV in patients with a history of kidney transplantation in Iran

 Published on 31/12/2025 |  Original article (Full-text)  | Heydari Sirat Sara et al. | BMC Infectious Diseases 2025; 25(1): 1740

Respiratory viruses are among the most prevalent human pathogens, accounting for a significant proportion of global mortality. These viruses spread rapidly within populations, causing acute infections and, in vulnerable groups, severe or chronic disease [1, 2]. They are characterized by relatively short...

Higher Urinary Iron Levels Are Associated with Kidney Dysfunction, Tubular Damage, and Increased Mortality in Kidney Transplant Recipients.

 Published on 24/12/2025 |  Original article (Full-text)  | Kremer, Daan et al. | Kidney360. Volume 6(11).

* Kidney transplant recipients have higher urinary iron levels than controls and urinary iron levels are increased with oral iron supplementation. * Urinary iron levels are associated with worse kidney function, increased tubular damage markers, and a higher mortality risk during follow-up....